Prostate epithelial cell differentiation and its relevance to the understanding of prostate cancer therapies.
about
Activation of an olfactory receptor inhibits proliferation of prostate cancer cellsGenome-wide impact of androgen receptor trapped clone-27 loss on androgen-regulated transcription in prostate cancer cellsMolecular aspects of prostate cancer with neuroendocrine differentiationPotential Cross-Talk between Alternative and Classical NF-κB Pathways in Prostate Cancer Tissues as Measured by a Multi-Staining Immunofluorescence Co-Localization AssayAndrogen deprivation by activating the liver X receptor.Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signalingGenetic ablation of the amplified-in-breast cancer 1 inhibits spontaneous prostate cancer progression in mice.Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors.GABA's control of stem and cancer cell proliferation in adult neural and peripheral niches.A novel signaling axis of matriptase/PDGF-D/ß-PDGFR in human prostate cancerIL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR.miR-200b inhibits prostate cancer EMT, growth and metastasisHuman Stromal Cells in the Peripheral Zone of the Prostate Promote Tumorigenesis of Prostatic Cancer Stem Cells through Up-regulation of C-Kit Expression.Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies.Chemo-hormone therapy of non-well-differentiated endocrine tumours from different anatomic sites with cisplatinum, etoposide and slow release lanreotide formulation.The significance of galectin-3 as a new basal cell marker in prostate cancer.Inhibition of monoamine oxidase A promotes secretory differentiation in basal prostatic epithelial cellsThe Drosophila Accessory Gland as a Model for Prostate Cancer and Other Pathologies.T-cadherin in prostate cancer: relationship with cancer progression, differentiation and drug resistanceNotch signaling in the prostate: critical roles during development and in the hallmarks of prostate cancer biology.The intercellular adhesion molecule, cadherin-10, is a marker for human prostate luminal epithelial cells that is not expressed in prostate cancer.Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer.Increased SNAIL expression and low syndecan levels are associated with high Gleason grade in prostate cancerThe culinary-medicinal mushroom Coprinus comatus as a natural antiandrogenic modulator.Primary cilia are lost in preinvasive and invasive prostate cancer.Prostate stem cells in the development of benign prostate hyperplasia and prostate cancer: emerging role and concepts.EGFR signaling pathway and related-miRNAs in age-related diseases: the example of miR-221 and miR-222.Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer.Combined analysis of EGF+61G>A and TGFB1+869T>C functional polymorphisms in the time to androgen independence and prostate cancer susceptibility.Effect of zinc and calcium ions on the rat kidney membrane-bound form of dipeptidyl peptidase IV.[Pathophysiology and therapy of benign prostatic hyperplasia].
P2860
Q24318917-BCB98025-24E9-47B2-BF4A-EB4FD14DF9E9Q24657502-D15EE1D2-8101-4A3C-88C5-9999B09A4A02Q26752910-1F295A02-E6EE-4010-AA6C-7718D2B9D263Q28546630-E9A6B4A2-D84D-4726-B86B-4C2EF984B0F6Q30439040-775B4434-0882-4415-9567-CAC28A16BDAAQ33632245-B1A5BDD9-BB69-4BF5-9310-14231C8BDD5CQ33967943-D71F726C-14B8-4DE0-9A0A-CB8443F63DA7Q34093594-BB0EF834-7758-4DCB-946F-89C32ECF82DEQ34099383-0480F4F3-5314-403F-AC35-B7696A9C4731Q34683885-0F9E1638-E8DF-445C-B6B6-1AD02E965832Q35037290-EFAC8633-CC9D-46D2-9B33-2C9D7D85A428Q35082717-4E1D8D6B-EFF2-4923-9C84-F5EA622AB0ABQ35856865-A9247366-B717-496E-AEB9-78F7C6054B57Q36272854-20EFE219-192D-433A-A937-3ACAEF839669Q36610457-934F0466-1CCE-49FC-9117-14DBA3162273Q37148238-B2FAF9A9-EA33-48DD-BB6D-8DE304E0CA3CQ37383756-0DFC86AE-B110-425F-934E-330040185EC4Q37577716-0860910E-1F89-47BB-8913-63D2C3DED3CDQ37601733-DEAA644B-7A36-4A09-B20C-B58EAD054DA9Q38367417-B8E86B4C-1962-4347-82DE-7F20453276E7Q38428634-E4958CB9-5CFB-4697-B295-474FFD4A5041Q38699173-F0A6F70E-22F8-47D2-A49D-85E83CEFD06BQ39034367-D9FACECF-07A7-4777-BB12-3816F194A9DEQ39621520-74F0E232-66CE-4504-B11D-D7811C664E3DQ41298456-290F1E76-0A0D-4ECC-9139-921724B5973EQ42154804-9BB90320-B22B-4501-8867-69EE360C1F2CQ42396355-85D70DFF-6C79-4B08-B1FE-A75C673E3A7BQ42593140-8565F9F5-9B3E-4CF0-B730-732329BA563AQ47674851-28BF664D-7C4F-4E41-8EEC-CD11CF76A322Q47795358-9A3C2289-E07F-442C-842A-3C4E0FAE94E9Q52588865-AD466E9C-3681-4154-89F0-3E5F5542E326
P2860
Prostate epithelial cell differentiation and its relevance to the understanding of prostate cancer therapies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Prostate epithelial cell diffe ...... of prostate cancer therapies.
@ast
Prostate epithelial cell diffe ...... of prostate cancer therapies.
@en
type
label
Prostate epithelial cell diffe ...... of prostate cancer therapies.
@ast
Prostate epithelial cell diffe ...... of prostate cancer therapies.
@en
prefLabel
Prostate epithelial cell diffe ...... of prostate cancer therapies.
@ast
Prostate epithelial cell diffe ...... of prostate cancer therapies.
@en
P2093
P356
P1433
P1476
Prostate epithelial cell diffe ...... of prostate cancer therapies.
@en
P2093
Colm Morrissey
John M Fitzpatrick
R William G Watson
Ronan M Long
P356
10.1042/CS20040241
P407
P577
2005-01-01T00:00:00Z